Valuation : GKB Ophthalmics Limited

Market Cap 370M 3.91M 3.36M 3.16M 2.88M 5.38M 5.41M 37.44M 14.48M 189M 14.67M 14.35M 602M P/E 2025
-4.32x
P/E 2026 21.7x
Enterprise Value 443M 4.67M 4.02M 3.78M 3.45M 6.43M 6.47M 44.76M 17.32M 226M 17.54M 17.15M 720M EV / Sales 2025
0.29x
EV / Sales 2026 0.23x
Free-Float
21.95%
Yield 2025 *
-
Yield 2026 -
08-12 GKB Ophthalmics Limited Reports Earnings Results for the First Quarter Ended June 30, 2026 CI
05-27 GKB Ophthalmics Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026 CI
02-12 GKB Ophthalmics Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2025 CI
11-14 GKB Ophthalmics Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2025 CI
15/08/25 GKB Ophthalmics Limited Reports Earnings Results for the First Quarter Ended June 30, 2025 CI
30/05/25 GKB Ophthalmics Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2025 CI
13/02/25 GKB Ophthalmics Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2024 CI
14/11/24 GKB Ophthalmics Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2024 CI
13/08/24 GKB Ophthalmics Limited Reports Earnings Results for the First Quarter Ended June 30, 2024 CI
30/05/24 GKB Ophthalmics Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024 CI
19/03/24 GKB Ophthalmics Limited Announces Resignation of Subhash Redkar as Executive Director / Whole Time Director CI
14/02/24 GKB Ophthalmics Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 CI
14/11/23 GKB Ophthalmics Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023 CI
1 day-9.99%
1 week+4.90%
Current month+3.33%
1 month+10.35%
3 months+5.14%
6 months+24.26%
Current year+29.06%
1 week 62.4
Extreme 62.4
73.7
1 month 58.39
Extreme 58.39
73.7
Current year 48.15
Extreme 48.15
76.9
1 year 45.25
Extreme 45.25
78.15
3 years 45.25
Extreme 45.25
136.4
5 years 45.25
Extreme 45.25
197.9
10 years 28.35
Extreme 28.35
209.2
Manager TitleAgeSince
Chief Executive Officer 84 10/12/1981
Director of Finance/CFO - 01/04/2019
Chief Administrative Officer 62 01/06/2024
Director TitleAgeSince
Chairman 84 10/12/1981
Director/Board Member 58 24/07/1996
Director/Board Member 68 20/06/2023
Change 5-day change 1-year change 3-year change Capi.($)
-9.99%+4.90%-8.39%-37.19% 3.91M
-2.01%-7.66%-43.63%-15.89% 79.97B
-0.66%-6.54%-11.99%-24.95% 33.36B
-2.73%-2.30%-1.60%-22.64% 13.2B
-0.27%+3.74% - - 12.76B
+0.50%+3.62%+1.94%+588.61% 2.71B
+0.64%-1.07%-39.55%-57.42% 1.47B
-0.07%+7.67% - - 967M
-0.92%-5.17%+15.16%+2.59% 916M
-0.88%-3.64%-37.65%-21.29% 879M
Average -1.64%+1.18%-15.71%+51.48% 14.62B
Weighted average by Cap. -1.52%-4.11%-30.06%-6.85%

Financials

2025 2026
Net sales 1.09B 11.5M 9.88M 9.3M 8.49M 15.84M 15.92M 110M 42.63M 557M 43.17M 42.23M 1.77B 1.49B 15.72M 13.52M 12.72M 11.61M 21.66M 21.77M 151M 58.3M 762M 59.04M 57.75M 2.42B
Net income -70.45M -743K -639K -601K -549K -1.02M -1.03M -7.12M -2.76M -36.01M -2.79M -2.73M -115M 12.18M 129K 111K 104K 94.88K 177K 178K 1.23M 477K 6.23M 483K 472K 19.82M
Net Debt 15.59M 164K 141K 133K 121K 227K 228K 1.58M 610K 7.97M 618K 604K 25.36M 72.38M 763K 656K 618K 564K 1.05M 1.06M 7.32M 2.83M 37M 2.87M 2.8M 118M
Logo GKB Ophthalmics Limited
GKB Ophthalmics Limited is engaged in manufacturing and sale of unfinished ophthalmic lenses. The Company is also focused on the business of manufacturing and supply of semi-finished plastic lenses. The Company operates through the Ophthalmics Lenses segment. Its products consist of organic semifinished lenses, which include single vision, bifocal, progressive and aspheric lenses. The single vision lenses include 1.498 CR-39, 1.50 BLUCHECK, 1.56 CLEAR, 1.56 BLUCHECK, 1.56 DAYNITE, 1.56 DAYNITE FAST CHANGE, 1.50 Q-SHADE+ and 1.50 SUNSENSOR. Its bifocal lenses include 1.498 CR-39, 1.50 BLUCHECK, 1.56 BLUCHECK, 1.56 DAYNITE, 1.56 DAYNITE FAST CHANGE and 1.50 Q-SHADE+. Its progressive lenses include 1.498 CR-39, 1.50 BLUCHECK, 1.56 DAYNITE and 1.56 DAYNITE FAST CHANGE. Its aspheric lens includes 1.498 CR-39. The Company’s products are exported to various countries across the globe. Its subsidiaries include GSV Ophthatmics Private Limited, GKB Ophthalmics Products FZE, and others.
Employees
156
Date Price Change Volume
09/09/26 66.13 -9.99% 7,176
08/09/26 ₹73.47 +9.66% 12,225
07/09/26 ₹67.00 +3.14% 889
04/09/26 ₹64.96 +3.05% 2,747
02/09/26 ₹63.04 +0.57% 1,360
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!